Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

LifeStance Health (LFST) Net Income towards Common Stockholders (2020 - 2025)

Historic Net Income towards Common Stockholders for LifeStance Health (LFST) over the last 6 years, with Q3 2025 value amounting to $1.1 million.

  • LifeStance Health's Net Income towards Common Stockholders rose 11807.96% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.1 million, marking a year-over-year increase of 9043.24%. This contributed to the annual value of -$57.4 million for FY2024, which is 6916.01% up from last year.
  • Latest data reveals that LifeStance Health reported Net Income towards Common Stockholders of $1.1 million as of Q3 2025, which was up 11807.96% from -$3.8 million recorded in Q2 2025.
  • In the past 5 years, LifeStance Health's Net Income towards Common Stockholders registered a high of $1.1 million during Q3 2025, and its lowest value of -$120.5 million during Q3 2021.
  • In the last 5 years, LifeStance Health's Net Income towards Common Stockholders had a median value of -$45.0 million in 2023 and averaged -$42.4 million.
  • Per our database at Business Quant, LifeStance Health's Net Income towards Common Stockholders plummeted by 355670.92% in 2021 and then surged by 11807.96% in 2025.
  • Over the past 5 years, LifeStance Health's Net Income towards Common Stockholders (Quarter) stood at -$108.0 million in 2021, then skyrocketed by 56.81% to -$46.7 million in 2022, then grew by 3.64% to -$45.0 million in 2023, then skyrocketed by 84.18% to -$7.1 million in 2024, then surged by 115.14% to $1.1 million in 2025.
  • Its Net Income towards Common Stockholders stands at $1.1 million for Q3 2025, versus -$3.8 million for Q2 2025 and $709000.0 for Q1 2025.